Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines
A Murayama, S Kamamoto, N Murata… - Journal of …, 2023 - Wiley Online Library
Background Clinical practice guidelines assist healthcare professionals in providing
evidence‐based care. However, pharmaceutical companies' financial interests often …
evidence‐based care. However, pharmaceutical companies' financial interests often …
A 9-year investigation of healthcare industry payments to pulmonologists in the United States
Rationale: The healthcare industry sometimes makes payments to physicians for
nonresearch and research purposes in the United States. Objectives: We aimed to evaluate …
nonresearch and research purposes in the United States. Objectives: We aimed to evaluate …
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
Background Self-regulation of payment disclosure by pharmaceutical industry trade groups
is a major global approach to increasing transparency of financial relationships between …
is a major global approach to increasing transparency of financial relationships between …
Research and nonresearch industry payments to nephrologists in the United States between 2014 and 2021
A Murayama, S Kamamoto, H Kugo… - Journal of the …, 2023 - journals.lww.com
Background Financial relationships between nephrologists and the health care industry
have been a concern in the United States over the past decade. Methods To evaluate …
have been a concern in the United States over the past decade. Methods To evaluate …
Nature and trends in personal payments made to the respiratory physicians by pharmaceutical companies in Japan between 2016 and 2019
Background: Financial relationships between healthcare professionals and pharmaceutical
companies have historically caused conflicts of interest and unduly influenced patient care …
companies have historically caused conflicts of interest and unduly influenced patient care …
Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database …
A Murayama, K Nakano, S Kamamoto, M Sato… - Clinical Microbiology …, 2022 - Elsevier
Objective To evaluate the trend in nonresearch payments made by the industries to the
infectious disease physicians in the United States since the launch of the Open Payments …
infectious disease physicians in the United States since the launch of the Open Payments …
Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021
A Murayama, S Kamamoto, K Higuchi… - The Journal of …, 2023 - jrheum.org
The Open Payments Database (OPD), the legally binding database of payments made by
pharmaceutical companies and device manufacturers to all physicians, 1 was launched in …
pharmaceutical companies and device manufacturers to all physicians, 1 was launched in …
[HTML][HTML] Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies …
There are prevalent financial relationships between dermatologists and pharmaceutical
companies in Japan. However, little was known about the extent of whole picture of the …
companies in Japan. However, little was known about the extent of whole picture of the …
Financial relationships between pharmaceutical companies and rheumatologists in Japan between 2016 and 2019
A Murayama, H Mamada, H Shigeta… - JCR: Journal of …, 2023 - journals.lww.com
Methods Using payment data publicly disclosed by 92 major pharmaceutical companies, we
evaluated the financial relationships between pharmaceutical companies and …
evaluated the financial relationships between pharmaceutical companies and …
Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
Objectives Limited evidence is available regarding the financial relationships between
gastroenterologists and pharmaceutical companies in Japan. This study analysed the …
gastroenterologists and pharmaceutical companies in Japan. This study analysed the …